Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Oxford Biomedica (OXB) Share Price

Price 632.00p on 26-02-2026 at 07:15:10
Change 0.00p 0%
Buy 975.00p
Sell 0.00p
Last Trade: Unknown 96,000.00 at 632.00p
Day's Volume: 0
Last Close: 632.00p
Open: 0.00p
ISIN: GB00BDFBVT43
Day's Range 0.00p - 0.00p
52wk Range: 232.50p - 950.00p
Market Capitalisation: £763.79m
VWAP: 0.00p
Shares in Issue: 120.85m

Oxford Biomedica (OXB) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 96,000 632.00p Negotiated Trade
17:18:07 - 25-Feb-26
Unknown* 1,300 632.00p OTC Trade
17:10:29 - 25-Feb-26
Buy* 25,796 632.024p SI Trade
16:56:01 - 25-Feb-26
Sell* 159,725 632.00p Uncrossing Trade
16:35:07 - 25-Feb-26
Sell* 223 628.00p Automatic Execution
16:29:55 - 25-Feb-26
Sell* 174 628.00p Automatic Execution
16:29:55 - 25-Feb-26
Sell* 26 628.00p Automatic Execution
16:29:36 - 25-Feb-26
Sell* 420 628.00p Automatic Execution
16:29:36 - 25-Feb-26
Buy* 201 630.00p Automatic Execution
16:28:57 - 25-Feb-26
Buy* 186 630.00p Automatic Execution
16:28:57 - 25-Feb-26
See more Oxford Biomedica trades

Oxford Biomedica (OXB) Share Price History

Time period:
to
Date Open High Low Close Volume
26th Feb 2026 (Thu) 632.00 632.00 632.00 632.00 0
25th Feb 2026 (Wed) 680.00 684.00 618.00 632.00 2,068,914
24th Feb 2026 (Tue) 757.00 757.00 667.00 683.00 1,118,844
23rd Feb 2026 (Mon) 783.00 791.00 765.00 774.00 689,300
20th Feb 2026 (Fri) 789.00 795.00 782.00 792.00 161,216
19th Feb 2026 (Thu) 780.00 805.00 780.00 790.00 144,309
18th Feb 2026 (Wed) 804.00 816.00 797.00 807.00 123,583
17th Feb 2026 (Tue) 819.00 819.00 783.00 806.00 221,615
16th Feb 2026 (Mon) 783.00 828.00 783.00 799.00 141,437
13th Feb 2026 (Fri) 809.00 825.00 792.00 823.00 224,455
12th Feb 2026 (Thu) 818.00 826.00 785.00 790.00 138,456
11th Feb 2026 (Wed) 823.00 867.00 808.00 816.00 404,750
10th Feb 2026 (Tue) 813.00 833.00 813.00 826.00 98,665
9th Feb 2026 (Mon) 809.00 833.00 809.00 830.00 118,398
6th Feb 2026 (Fri) 800.00 814.00 795.00 809.00 158,941
5th Feb 2026 (Thu) 818.00 826.00 810.00 812.00 154,372
4th Feb 2026 (Wed) 824.00 862.00 817.00 826.00 629,787
3rd Feb 2026 (Tue) 833.00 847.00 813.00 818.00 300,162
2nd Feb 2026 (Mon) 825.00 832.00 809.00 830.00 303,247
30th Jan 2026 (Fri) 845.00 850.00 831.00 831.00 345,561
29th Jan 2026 (Thu) 855.00 862.00 844.00 850.00 228,215
28th Jan 2026 (Wed) 862.00 888.00 855.00 855.00 356,464
27th Jan 2026 (Tue) 872.00 880.00 858.00 869.00 404,918
26th Jan 2026 (Mon) 870.00 879.00 860.00 864.00 114,450
See more Oxford Biomedica price history

Oxford Biomedica (OXB) Regulatory News

Date Source Headline
25th Feb 2026 3:20 pm RNS Form 8.3 - Oxford Biomedica plc
25th Feb 2026 2:32 pm RNS Form 8.5 (EPT/RI)-Replacement of Oxford Biomedica
25th Feb 2026 12:33 pm RNS Response to Rule 2.8 Announcement
25th Feb 2026 12:12 pm RNS Disclosure Table
25th Feb 2026 12:00 pm RNS Rule 2.8 Announcement
25th Feb 2026 11:46 am RNS Form 8.3 - Oxford Biomedica plc
25th Feb 2026 10:53 am RNS Form 8.5 (EPT/NON-RI) Oxford Biomedica Plc
25th Feb 2026 10:17 am RNS Form 8.5 (EPT/RI) - Oxford Biomedica plc
25th Feb 2026 10:15 am RNS Form 8.5 (EPT/NON-RI) - Oxford Biomedica plc
24th Feb 2026 7:29 am RNS Form 8.5 (EPT/RI)-Oxford Biomedica plc
See more Oxford Biomedica regulatory news

Oxford Biomedica (OXB) Share News

EQT abandons Oxford BioMedica takeover bid after proposals rejected

25th Feb 2026 16:02

(Alliance News) - EQT Fund Management SARL confirmed on Wednesday it has no intention of making an offer for Oxford BioMedica PLC. Read More

Oxford BioMedica revenue climbs 30% in 2025 as backlog grows

24th Feb 2026 09:48

(Alliance News) - Oxford BioMedica PLC on Tuesday said it expects to report revenue at the upper end of guidance as contracted orders increased. Read More

Oxford BioMedica expands cancer therapy deal with Bristol-Myers Squibb

4th Feb 2026 11:57

(Alliance News) - Oxford BioMedica PLC on Wednesday said it has signed a new commercial supply deal with Bristol-Myers Squibb Co. Read More

IN BRIEF: Oxford Biomedica confirms fresh EQT takeover approach

14th Jan 2026 18:53

Oxford BioMedica PLC - Oxford, England-based gene and cell therapy developer - Says it notes recent press speculation and that it has received an unsolicited approach, regarding a possible cash takeover offer, from EQT X EUR SCSp and EQT X USD SCSp, funds managed by EQT Fund Management Sarl. Says it and EQT are in preliminary discussions to explore whether EQT could make a proposal which OXB's board would want to recommend. Previous unsolicited proposals from EQT have been rejected, as OXB's board believed they undervalued it and its prospects. Company "strongly" advises shareholders to take no action at this time. Read More

LONDON BROKER RATINGS: Berenberg raises M&S; BofA cuts Barratt Redrow

9th Jan 2026 10:04

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

See more Oxford Biomedica news
FTSE 100 Latest
Value10,806.41
Change0.00

Login to your account

Forgot Password?

Not Registered